Your browser doesn't support javascript.
loading
Decreased plasma acetaminophen glucuronide/acetaminophen concentration ratio warns the onset of acetaminophen-induced liver injury.
Noda, Takumi; Kato, Ryuji; Ozato, Yasuyuki; Kawai, Yuka; Yamamoto, Masato; Kagawa, Yuya; Azuma, Misa; Yamamoto, Kojiro; Kusanagi, Mika; Uryu, Kiyoaki; Harada, Hiromasa; Ijiri, Yoshio; Hayashi, Tetsuya; Tanaka, Kazuhiko.
Afiliación
  • Noda T; Department of Cardiovascular Pharmacotherapy and Toxicology, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, 4-20-1 Nasahara, Takatsuki, Osaka, 569-1094, Japan.
  • Kato R; Department of Cardiovascular Pharmacotherapy and Toxicology, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, 4-20-1 Nasahara, Takatsuki, Osaka, 569-1094, Japan.
  • Ozato Y; Yao Tokusyukai General Hospital, 1-17 wakakusacho, Yao, Osaka, 581-0011, Japan.
  • Kawai Y; Department of Cardiovascular Pharmacotherapy and Toxicology, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, 4-20-1 Nasahara, Takatsuki, Osaka, 569-1094, Japan.
  • Yamamoto M; Department of Cardiovascular Pharmacotherapy and Toxicology, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, 4-20-1 Nasahara, Takatsuki, Osaka, 569-1094, Japan.
  • Kagawa Y; Department of Cardiovascular Pharmacotherapy and Toxicology, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, 4-20-1 Nasahara, Takatsuki, Osaka, 569-1094, Japan.
  • Azuma M; Department of Cardiovascular Pharmacotherapy and Toxicology, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, 4-20-1 Nasahara, Takatsuki, Osaka, 569-1094, Japan.
  • Yamamoto K; Yao Tokusyukai General Hospital, 1-17 wakakusacho, Yao, Osaka, 581-0011, Japan.
  • Kusanagi M; Yao Tokusyukai General Hospital, 1-17 wakakusacho, Yao, Osaka, 581-0011, Japan.
  • Uryu K; Yao Tokusyukai General Hospital, 1-17 wakakusacho, Yao, Osaka, 581-0011, Japan.
  • Harada H; Yao Tokusyukai General Hospital, 1-17 wakakusacho, Yao, Osaka, 581-0011, Japan.
  • Ijiri Y; Department of Cardiovascular Pharmacotherapy and Toxicology, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, 4-20-1 Nasahara, Takatsuki, Osaka, 569-1094, Japan.
  • Hayashi T; Department of Cardiovascular Pharmacotherapy and Toxicology, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, 4-20-1 Nasahara, Takatsuki, Osaka, 569-1094, Japan.
  • Tanaka K; Department of Cardiovascular Pharmacotherapy and Toxicology, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, 4-20-1 Nasahara, Takatsuki, Osaka, 569-1094, Japan.
Biopharm Drug Dispos ; 43(3): 108-116, 2022 Jun.
Article en En | MEDLINE | ID: mdl-35508086
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad Hepática Inducida por Sustancias y Drogas / Enfermedad Hepática Crónica Inducida por Sustancias y Drogas Tipo de estudio: Etiology_studies Límite: Animals / Humans Idioma: En Revista: Biopharm Drug Dispos Año: 2022 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad Hepática Inducida por Sustancias y Drogas / Enfermedad Hepática Crónica Inducida por Sustancias y Drogas Tipo de estudio: Etiology_studies Límite: Animals / Humans Idioma: En Revista: Biopharm Drug Dispos Año: 2022 Tipo del documento: Article País de afiliación: Japón